Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins, Minerals), And Segment Forecasts, 2013 - 2024

Industry Insights

The global parenteral nutrition market size was valued at USD 4.74 billion in 2016 and is expected to grow at a CAGR of 5.7% over the forecast period. The market is expected to witness lucrative growth over the forecast period owing to parameters such as high natality rates across the globe, presence of a large pool of malnourished children, rising premature births, growing adoption by healthcare settings for nutrient administration in chronically ill geriatric patients, and rising prevalence rate of cancer which require administration of vital nutrients to increase the strength, energy, and hydration of cancer patients. 

Majority of the premature babies suffer from low weight and undeveloped immunity thereby putting them at risk. Parenteral nutrition diminishes the risk of infection and underdevelopment, thereby promoting its application. The demand for parenteral nutrition is higher in very low birth weight (VLBW) newborns. Use of parenteral nutrition, in premature infants, leads to faster neurological development, improved intrauterine nutrient deposition, and minimized the risk of complications, thereby improving their chances for survival.

Natality rate indicates the total number of birth per 1,000 people and is useful to understand the rise in population of a particular region. Rising natality rate is a vital impact-rendering driver for market growth. An article published in 2015 in the Wall Street Journal, stating data from the Centers for Disease Control and Prevention (CDC) had predicted that in the U.S. the natality rate is expected to rise owing to improving fertility rate as well as progressive economic conditions. In addition, the increasing preterm births and rising complications during labor also increases the demand for parenteral nutrition. 

Malnutrition is also one amongst the major drivers of this market. According to the UNICEF, poor nutrition in the first 1,000 days of an infant’s life may lead to impaired cognitive ability and stunted growth. An infant’s diet must contain a proper balance of starch, minerals, vitamins, amino acids and lipids. These essential nutrients can be administered through parenteral nutrition, which is expected to boost the market.

According to the study conducted by the United States Department of Agriculture (USDA) as of 2013, more than 15.0 million individuals up to the age of 18 are living in households that are unable to provide nutritious food. In addition, organizations such as the American Society for Parenteral and Enteral Nutrition (ASPEN) had initiated programs such as the Malnutrition Awareness Week to raise awareness among patients and healthcare providers.

The presence of large population above 60 years, suffering from low immunity levels and prone to neurological diseases, cardiac problems, treatment required by this population includes parenteral nutrition as well. Therefore, the growing geriatric population base is likely to increase the demand for parenteral nutrition over the forecast period.

Nutrient Type Insights

Key nutrient type segments include carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins & minerals.  Advanced product segment that comprises moist, antimicrobial and active products dominated the overall industry, commanding over 56.1% revenue share in 2014. Advanced wound care therapy is indispensable for treatment of chronic and non-healing wounds. The dominance of this segment can be attributed to high usage and improved utility of products.

Single dose amino acid solutions accounted for the dominant share in 2015. The growing usage of amino acid solutions and the influx of regulatory approved solutions contributed to the large share commanded by this segment. Moreover, currently available amino acid solutions pose fewer side effects, thereby enhancing patient benefits.

Parenteral lipid emulsion segment is estimated to register the fastest growth over the forecast period. Lipid emulsions are intended for intravenous use, which supplements the body with fatty acids, fat-soluble vitamins and calories.

Lipid emulsion therapy is usually given to patients as a cardio-protective agent, vehicle for the administration of other medications, nutritional support and to reduce local anesthetic toxicity. In addition, they also act as an antidote for local anesthetic systemic toxicity (LAST). Intralipid, a Baxter International product has become a brand name for lipid emulsion due to its common use. The other commonly used products in this segment include Nutrilipid and Liposyn.

Regional Insights

The North American parenteral nutrition market commanded a dominant share in 2015, with over 41.3% of the revenue share. The large share commanded by this regional segment can be attributed to the presence of high research expenditure by private entities and government agencies in the healthcare sector, technologically advanced medical devices, and collaborations among medical device industry, regulatory authorities, universities, and others.

Additionally, growing prevalence of various chronic diseases, presence of sophisticated healthcare facilities and favorable reimbursement policies has led to high hospital admission rates that in turn is expected to boost usage rates in this region.

Asia Pacific parenteral nutrition market is expected to witness lucrative growth over the forecast period. Economic development in countries such as India, China and Japan, coupled with favorable government initiatives pertaining to the development of healthcare infrastructure and reimbursement policies is expected to fuel market growth. Furthermore, increasing Foreign Direct Investment (FDI) initiatives in medical devices and healthcare sector by various government and private organization are expected to provide incentives for the manufacture of technologically-advanced products over the forecast period.

According to UNICEF, the region encompasses of various developing and the third world countries, wherein over two billion individuals suffer from malnutrition. The growing prevalence of malnutrition in the Asia-Pacific region is also likely to bolster market growth over the forecast period.

Parenteral Nutrition Market Share Insights

Key players of the parenteral nutrition market include B. Braun Melsungen AG, Fresenius Kabi AG, Allergan plc, Grifols, S.A., Hospira (acquired by Pfizer, Inc.), Otsuka Pharmaceutical Factory Inc., Baxter International, Inc., Sichuan Kelun Pharmaceutical Co., Ltd., Vifor Pharma, and Aculife Healthcare 

The industry is highly competitive and dynamic in nature with several players competing to gain revenue share. The increase in demand for branded and high-quality products also favors the companies operating in this market. The entry of new players is likely to increase competitive rivalry over the forecast period. In addition, strategic initiatives such as price reduction strategies, the launch of technologically advanced products, and marketing promotions undertaken by key players are further likely to fuel fierce competition in this market.  

For instance, in April 2016, Baxter received marketing authorization in the UK and Denmark for NUMETA G13 E which is a ready-to-use I.V. nutrition for premature infants. This is expected to increase their market share in the region.

In December 2015, Fresenius Kabi doubled the production capacity of the plant in Spain, which resulted in increased production of infusion solutions. This plant primarily operates for the European region and is expected to increase the company’s share in this region.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2013 to 2024. For the purpose of this study, Grand View Research, Inc. has segmented the global parenteral nutrition market report on the basis of nutrient type and region:

• Nutrient Type Outlook (Revenue, USD Million, 2013 - 2024)

  • Carbohydrates

  • Parenteral lipid emulsion

  • Single dose amino acid solution

  • Trace elements

  • Vitamins & minerals

• Regional Outlook (Revenue, USD Million, 2013 - 2024)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia